Previous 10 | Next 10 |
Summary Establishment Labs presents with unique exposure to the aesthetic and constructive surgery market. Whilst the sector is poised for continued growth the same can't be said for ESTA, who've lagged market growth in periods to date. Loss on invested capital and a lack of p...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that it will host an investor event on October 5, 2022 to discuss Mia Femtech ® (“...
Hani Zeini is a 20+ year executive in the breast aesthetics industry, including as CEO and Founder of Sientra Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction...
"In our view, ESTA is on the cusp of a transformative 2023 with the prospect of almost tripling its addressable market in breast augmentation (in ~$1.5B global market) through expected U.S./China Motiva launches and by meaningfully expanding the market with its novel Motiva MIA minimally ...
Establishment Labs Holdings, Inc. (ESTA) Q2 2022 Earnings Conference Call August 08, 2022 04:30 PM ET Company Participants Juan Jose Chacon Quiros - Founder and CEO Rajbir Denhoy - CFO Conference Call Participants Chris Cooley - Stephens Zach Weiner -...
Establishment Labs press release ( NASDAQ: ESTA ): Q2 GAAP EPS of -$1.52 misses by $1.13 . Revenue of $41.2M (+28.7% Y/Y) beats by $2.81M . FY22 revenue guidance of between $155M and $165M, vs. consensus of $161.73M, maintained. For further details see: ...
Establishment Labs Holdings Inc. (Nasdaq: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its financial results for the second quarter ended June 30, 2022. ...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced it has completed enrollment in the Motiva US IDE clinical study. The final...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2022 after the mark...
Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced publication of its 2021 Sustainability Review to coincide with the fourth ...
News, Short Squeeze, Breakout and More Instantly...
Establishment Labs Holdings Inc. Company Name:
ESTA Stock Symbol:
NASDAQ Market:
Establishment Labs Holdings Inc. Website:
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA : Nasdaq NEW YORK, NY, June 17, 2024 - (ACN Newswire) - Findell Capital Management LLC, an investment management firm, today announced the release of a detailed Report on Establishment Labs Holdin...
--News Direct-- New York, NY, June 17, 2024 – Findell Capital Management LLC , an investment management firm, today announced the release of a detailed Report on Establishment Labs Holdings Inc. (Nasdaq: ESTA), which can be found here . ESTA is a NASDAQ listed c...
2024-05-20 18:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...